CervoMed (STU:DP8) FCF Margin %: 0.00% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:DP8 CervoMed Inc STU:DP8
41 GF Score
Price €2.24
! 2 Warning Signs
View Full Analysis

What is CervoMed FCF Margin %?

CervoMed STU:DP8 +0.90% 41 FCF Margin % is 0.00% as of Jun. 2026. GuruFocus rates STU:DP8 with a GF Score™ of 41/100. The stock has 2 warning signs investors should review. Among 960 Biotechnology companies, CervoMed ranks worse than 104166.56% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. CervoMed's Free Cash Flow for the three months ended in Jun. 2026 was €-6.01 Mil. CervoMed's Revenue for the three months ended in Jun. 2026 was €0.00 Mil. Therefore, CervoMed's FCF Margin % for the quarter that ended in Jun. 2026 was 0.00%.

As of today, CervoMed's current FCF Yield % is -69.18%.

The historical rank and industry rank for CervoMed's FCF Margin % or its related term are showing as below:


STU:DP8's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -77.695
* Ranked among companies with meaningful FCF Margin % only.

CervoMed FCF Margin % Related Terms

CervoMed FCF Margin % Historical Data

* Premium members only.

The historical data trend for CervoMed's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CervoMed FCF Margin % Chart

CervoMed Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CervoMed Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

STU:DP8 vs ACTU, KPTI, ALGS: FCF Margin % Comparison

For the Biotechnology subindustry, CervoMed's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CervoMed FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CervoMed's FCF Margin % distribution charts can be found below:

* The bar in red indicates where CervoMed's FCF Margin % falls into.


STU:DP8
41GF Score
CervoMed Inc STU:DP8
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CervoMed FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

CervoMed's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-20.026/0
= %

CervoMed's FCF Margin for the quarter that ended in Jun. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Jun. 2026 )/Revenue (Q: Jun. 2026 )
=-6.005/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
CervoMed (STU:DP8) has a FCF Margin % of 0.00% as of Jun. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on CervoMed and its competitors. According to the industry distribution chart, CervoMed ranks #999999 out of 960 companies in the Biotechnology industry.
Is CervoMed's FCF Margin % too high?
CervoMed's current FCF Margin % is 0.00%. Based on the distribution chart, CervoMed ranks #999999 out of 960 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, CervoMed has a GF Score™ of 41/100, reflecting its overall financial health beyond just this single metric.
How does CervoMed's FCF Margin % compare to ACTU and KPTI?
According to the Biotechnology industry distribution chart, CervoMed ranks #999999 out of 960 companies for FCF Margin %. This places CervoMed in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on CervoMed and its competitors. CervoMed's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CervoMed stock overvalued right now?
CervoMed (STU:DP8) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. CervoMed's overall GF Score™ is 41/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For CervoMed (STU:DP8), the current FCF Margin % is 0.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CervoMed Business Description

Other Exchanges CRVO:USA
Address 20 Park Plaza, Suite 424, Boston, MA, USA, 02116
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
41GF Score

Get the complete analysis for STU:DP8

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.24
Price